View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Hybridan Small Cap Feast - 27 November 2024

Status of this Note and Disclaimer This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The i...

Colin Smith
  • Colin Smith

Polarean Imaging Initiation - On the cusp of hyperbolic growth

Despite initial FDA approval and grant of the requisite reimbursement codes, investor confidence in Polarean is low, as reflected in the current share price. However, revenue growth is already accelerating and is set to go hyperbolic as Polarean's Xenon MRI platform meets a large unmet clinical need that cannot be satisfied by other methods. Crossing the bridge to profitability will require additional funding but there is a cash runway through 1Q26. Polarean has potential upside many times its c...

 PRESS RELEASE

FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems

FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems Expands accessibility for institutions utilizing GE HealthCare MRI systems DURHAM, NC and LONDON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Company’s specialized MRI Chest Coil to now include GE HealthCare 3 Tesla (3T) MRI scanners for the visualization ...

Thermo Fisher Scientific Inc: 1 director

A director at Thermo Fisher Scientific Inc sold 9,000 shares at 552.863USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Hybridan Small Cap Feast - 30 October 2024

* A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Dish of the day Admissions: None Delistings: Gulf Investment Fund (GIF.L) has delisted from the specialist fund segment of the main market What’s baking in the oven? ITF announced:*** Potential** Initia...

Hybridan Small Cap Feast - 28 October 2024

28th October 2024 * A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Dish of the day Admissions: None Delistings: Harland & Wolff Group Holdings plc (HARL.L) has delisted from AIM. What’s baking in the oven? ITF announced:*** Potential** Initial Public ...

Hybridan Small Cap Feast - 24 October 2024

24th October 2024 * A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Dish of the day Admissions: Applied Nutrition (APN.L), the sports nutrition, health and wellness brand has confirmed its first day of dealings on the main market. The Offer Price has b...

Hybridan Small Cap Feast - 16 October 2024

* A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Today’s Small Cap Feast is dedicated to Professor Richard Conroy who sadly passed away recently after a short illness. Richard was known to many in the market as Chairman of both Conroy Gold & Natural R...

Hybridan Small Cap Feast - 14 October 2024

* A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Dish of the day Admissions: None Delistings: None What’s baking in the oven? ITF announced:*** Potential** Initial Public Offerings: 30th September 2024: Applied Nutrition, the sports nutrition, health ...

Hybridan Friday Takeaway - 4 October 2024

AUK- Smart Growth CCT- Character Built IKA – Waiting for a Power Surge ITG – Stimulated Real Value Aukett Swanke 1.675p £5.7m (AUK.L) The original architecture practice was founded in 1906 and recently it formed a Smart Buildings division whose first combined interims to March 2024 were reported on 28 June. Revenue, including the new businesses, escalated to £9.45m from £4.56m but there was, however, an increased trading loss to £0.81m from £0.29m due to the process of transforming itself from p...

Hybridan Small Cap Feast - 2 October 2024

2nd October 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: GenIP (GNIP.L) listed today on the AIM market raising £1.75m at 39 pence per share at a £6.8m market cap. GenIP is a portfolio company of London-based intellectual property investor Tekcapital PLC (TEK.L) who still own 63% of GEN. Its platforms provi...

Hybridan Small Cap Feast - 16 September 2024

16th September 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: None Delistings: Vector Capital (VCAP.L) has delisted from AIM What’s baking in the oven? Our daily digest of news from UK Small Caps If you would like to unsubscribe, please email with “unsubscribe me”. Hybridan Chefs Banquet Buffet*** Acuity...

 PRESS RELEASE

Appointment of Alan Huang, PhD, as Vice President of Sales

Appointment of Alan Huang, PhD, as Vice President of Sales Experienced business leader with extensive commercial experience in Magnetic Resonance Imaging DURHAM, NC and LONDON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, is pleased to announce the appointment of Alan Huang, PhD as Vice President of Sales. Dr. Huang brings extensive knowledge and 15 years of experience in the medical device industry, with specific expertise in M...

 PRESS RELEASE

Appointment of Chase Hall, M.D., as Chief Medical Advisor

Appointment of Chase Hall, M.D., as Chief Medical Advisor Adds significant pulmonary expertise to help drive engagement with the medical community DURHAM, NC and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces that it has appointed Chase Hall, M.D., as Chief Medical Advisor. Dr. Hall is an Associate Professor, Pulmonary, Critical Care and Sleep Medicine, at the University of Kansas Medical Center in the Division of Pulmonary and Critical Care...

DIS DISTIL
EQT EQTEC ... (+8)

Hybridan Small Cap Feast - 14 August 2024

14th August 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: None Delistings: None What’s baking in the oven? ** Our daily digest of news from UK Small Caps If you would like to unsubscribe, please email with “unsubscribe me”. Hybridan Chefs Banquet Buffet*** Crossword Cybersecurity* 4.4p £4.9m (CCS.L) The...

Hybridan Small Cap Feast - 30 July 24

30th July 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: Mining, Minerals & Metals Plc (MMM.L) has completed the acquisition of Georgina Energy Plc and will now be trading on the London Stock Exchange under the name Georgina Energy plc (GEX.L). Georgina is an early-stage well redevelopment company which has ...

Hybridan Small Cap Feast - 28 June 2024

28th June 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: Delistings: Startup Giants (SUG) has withdrawn from Aquis Stock Exchange What’s baking in the oven? ** Potential**** Initial Public Offerings: ITF announced: 19 June 2024: IntelliAM, an artificial intelligence company focused on the consumer goods indu...

Thermo Fisher Scientific Inc.: Update following outlook change to posi...

Our credit view of this issuer reflects its significant scale and good diversification, constrained by its appetite for large acquisitions and shareholder-friendly financial policies

 PRESS RELEASE

Polarean Raises $12.6 Million in Oversubscribed Financing Round to Acc...

Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives Financing led by existing and new investors DURHAM, NC and LONDON, June 20, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging (MRI) of the lungs, announces the closing of a $12.6 million oversubscribed financing via the Alternative Investment Market (AIM) of the London Stock Exchange. The fundraise was co-led by strategic investors ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch